763 related articles for article (PubMed ID: 17063116)
1. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
3. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1170-6. PubMed ID: 16890027
[TBL] [Abstract][Full Text] [Related]
4. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease.
Kemp W; Pianko S; Nguyen S; Bailey MJ; Roberts SK
J Gastroenterol Hepatol; 2005 Jun; 20(6):873-81. PubMed ID: 15946134
[TBL] [Abstract][Full Text] [Related]
5. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
8. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
[TBL] [Abstract][Full Text] [Related]
10. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
14. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
16. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A; Michitaka K; Horiike N; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Sogabe I; Ishimaru Y; Kawasaki H; Koizumi Y; Hirooka M; Yamashita Y; Abe M; Hiasa Y; Matsuura B; Onji M
J Gastroenterol Hepatol; 2010 Feb; 25(2):403-7. PubMed ID: 19929922
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Motoyoshi Y; Shibata H; Eguchi K
Oncol Rep; 2005 Oct; 14(4):999-1003. PubMed ID: 16142364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
